Response to " germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng.
作者信息
Aizenbud Lilach, Schoenfeld David A, Caulfield Jasmine I, Mann Jacqueline E, Austin Matthew R, Perdigoto Ana Luisa, Herold Kevan C, Kluger Harriet M
机构信息
Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Medicine (Endocrinology and Metabolism), Yale University School of Medicine, New Haven, Connecticut, USA.
出版信息
J Immunother Cancer. 2023 Jun;11(6). doi: 10.1136/jitc-2023-007397.
Abstract
摘要
相似文献
1
Response to " germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng.对孟祥宇所著《种系变体及其在接受免疫检查点抑制剂治疗的癌症患者引发免疫反应中的潜在作用》的回应
J Immunother Cancer. 2023 Jun;11(6). doi: 10.1136/jitc-2023-007397.
2
germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors.种系变异作为免疫检查点抑制剂潜在的药物基因组学标志物。
J Immunother Cancer. 2023 Jun;11(6). doi: 10.1136/jitc-2023-007255.
3
Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors.胚系遗传变异与接受免疫检查点抑制剂治疗的癌症患者发生胰岛素依赖型糖尿病有关。
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-006570.
4
Re: Germline Variants Associated with Toxicity to Immune Checkpoint Blockade.关于：与免疫检查点阻断毒性相关的种系变异。
Eur Urol. 2023 Dec;84(6):597. doi: 10.1016/j.eururo.2023.03.008. Epub 2023 Mar 22.
5
Beyond probiotics: postbiotics sensitize cancer cells to immune checkpoint inhibitors.超越益生菌：后生元使癌细胞对免疫检查点抑制剂敏感。
Trends Cancer. 2024 Jan;10(1):5-7. doi: 10.1016/j.trecan.2023.12.001. Epub 2023 Dec 14.
6
Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma.胚系变异在外显子区域对晚期黑色素瘤免疫检查点阻断的临床结局影响有限。
Pigment Cell Melanoma Res. 2021 Sep;34(5):978-983. doi: 10.1111/pcmr.12958. Epub 2021 Jan 24.
7
NLRC5/CITA expression correlates with efficient response to checkpoint blockade immunotherapy.NLRC5/CITA 表达与检查点阻断免疫治疗的有效反应相关。
Sci Rep. 2021 Feb 5;11(1):3258. doi: 10.1038/s41598-021-82729-9.
8
Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report.尽管存在表皮生长因子受体（EGFR）种系突变，但转移性非小细胞肺癌（NSCLC）对免疫检查点抑制剂仍有长期反应。病例报告。
Lung Cancer. 2022 Dec;174:186-187. doi: 10.1016/j.lungcan.2022.09.005. Epub 2022 Sep 10.
9
HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started.HLA 基因分型与免疫检查点抑制剂反应预测：一个刚刚开始的故事。
Int J Immunogenet. 2021 Apr;48(2):193-200. doi: 10.1111/iji.12517. Epub 2020 Oct 28.
10
Multitumor Case Series of Germline , and -Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors.多瘤种病例系列：种系和 - 突变患者对免疫检查点抑制剂有良好反应。
Curr Oncol. 2021 Aug 24;28(5):3227-3239. doi: 10.3390/curroncol28050280.
本文引用的文献
1
NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity.NLRC5-CIITA 融合蛋白可有效诱导 MHC-I 表达和抗肿瘤免疫。
Int J Mol Sci. 2023 Apr 13;24(8):7206. doi: 10.3390/ijms24087206.
2
Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors.胚系遗传变异与接受免疫检查点抑制剂治疗的癌症患者发生胰岛素依赖型糖尿病有关。
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-006570.
3
HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events.HLA 与肿瘤免疫学：免疫逃逸、免疫治疗和免疫相关不良事件。
J Cancer Res Clin Oncol. 2023 Feb;149(2):737-747. doi: 10.1007/s00432-022-04493-1. Epub 2023 Jan 20.
4
Response to Immune Checkpoint Inhibitors Is Affected by Deregulations in the Antigen Presentation Machinery: A Systematic Review and Meta-Analysis.抗原呈递机制失调对抗免疫检查点抑制剂的反应的影响：一项系统综述和荟萃分析。
J Clin Med. 2022 Dec 31;12(1):329. doi: 10.3390/jcm12010329.
5
NLRC5/CITA expression correlates with efficient response to checkpoint blockade immunotherapy.NLRC5/CITA 表达与检查点阻断免疫治疗的有效反应相关。
Sci Rep. 2021 Feb 5;11(1):3258. doi: 10.1038/s41598-021-82729-9.
6
Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma.抗原加工和呈递机制的基因特征可预测非小细胞肺癌 (NSCLC) 和黑色素瘤对检查点阻断的反应。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-000974.
Zotero 插件